Bliss GVS Pharma

Bliss GVS Pharma Ltd Nine Monthly Results

NSEBSE

₹111.84

(-0.21%)

May 9, 2025|12:00:00 AM

Invest wise with Expert advice

Financials

ConsolidatedStandalone

Select Period

Particulars (Rupees in Crores.)	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020
Gross Sales	611.74	572.12	566.81	580.39	445.15
Excise Duty	0	0	0	0	0
Net Sales	611.74	572.12	566.81	580.39	445.15
Other Operating Income	0	0	0	0	0
Other Income	24.43	23.14	14.81	19.3	13.9
Total Income	636.17	595.25	581.62	599.69	459.05
Total Expenditure	506.14	449.84	455.73	555.81	355.39
PBIDT	130.02	145.41	125.89	43.88	103.66
Interest	6.44	5.06	5.28	3.11	3.15
PBDT	123.58	140.35	120.61	40.77	100.51
Depreciation	21.38	19.53	13.79	13.06	12.96
Minority Interest Before NP	0	0	0	0	0
Tax	33.48	24.83	35.5	33.75	21.01
Deferred Tax	-4.88	9.5	-1.95	-5.7	0.72
Reported Profit After Tax	73.6	86.49	73.27	-0.34	65.82
Minority Interest After NP	4.84	1.89	5.75	4.25	3.57
Net Profit after Minority Interest	68.76	84.6	67.52	-4.59	62.25
Extra-ordinary Items	0	0	0	16.05	0
Adjusted Profit After Extra-ordinary item	68.76	84.6	67.52	-20.64	62.25
EPS (Unit Curr.)	6.55	8.11	6.49	-0.44	6.03
Book Value (Unit Curr.)	0	0	0	0	0
Dividend (%)	0	0	0	0	0
Equity	10.54	10.47	10.37	10.37	10.31
Public Shareholding (Number)	0	0	0	0	0
Public Shareholding (%)	0	0	0	0	0
Pledged/Encumbered - No. of Shares	0	0	0	0	0
Pledged/Encumbered - % in Total Promoters Holding	0	0	0	0	0
Pledged/Encumbered - % in Total Equity	0	0	0	0	0
Non Encumbered - No. of Shares	0	0	0	0	0
Non Encumbered - % in Total Promoters Holding	0	0	0	0	0
Non Encumbered - % in Total Equity	0	0	0	0	0
PBIDTM(%)	21.25	25.41	22.21	7.56	23.28
PBDTM(%)	20.2	24.53	21.27	7.02	22.57
PATM(%)	12.03	15.11	12.92	-0.05	14.78

No Record Found

Invest wise with Expert advice